Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-165331
Filing Date
2021-05-18
Accepted
2021-05-18 16:11:15
Documents
8
Effectiveness Date
2021-05-18

Document Format Files

Seq Description Document Type Size
1 S-8 d512029ds8.htm S-8 62946
2 EX-4.4 d512029dex44.htm EX-4.4 66228
3 EX-4.5 d512029dex45.htm EX-4.5 65672
4 EX-5.1 d512029dex51.htm EX-5.1 7688
5 EX-23.1 d512029dex231.htm EX-23.1 1455
6 GRAPHIC g512029g01h09.jpg GRAPHIC 4350
7 GRAPHIC g512029g11a23.jpg GRAPHIC 10483
8 GRAPHIC g512029g66s53.jpg GRAPHIC 3144
  Complete submission text file 0001193125-21-165331.txt   230493
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-256255 | Film No.: 21936070
SIC: 2834 Pharmaceutical Preparations